Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nathan Thomas Kudlapur, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nathan Kudlapur's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nathan Kudlapur has written about over time.
Amino Acid Substitution, 1 publications between 2021 and 2021, average publication date September 2021. Bone Diseases, 1 publications between 2021 and 2021, average publication date September 2021. Diabetes Mellitus, 1 publications between 2021 and 2021, average publication date September 2021. Genetic Diseases, Inborn, 1 publications between 2021 and 2021, average publication date September 2021. Glutamate-tRNA Ligase, 1 publications between 2021 and 2021, average publication date September 2021. HEK293 Cells, 1 publications between 2021 and 2021, average publication date September 2021. Male, 1 publications between 2021 and 2021, average publication date September 2021. Mutation, Missense, 1 publications between 2021 and 2021, average publication date September 2021. Stress, Physiological, 1 publications between 2021 and 2021, average publication date September 2021. Humans, 2 publications between 2021 and 2023, average publication date July 2022. Cohort Studies, 1 publications between 2023 and 2023, average publication date April 2023. Prospective Studies, 1 publications between 2023 and 2023, average publication date April 2023. Sensitivity and Specificity, 1 publications between 2023 and 2023, average publication date April 2023.

To see the data from this visualization as text, click here.
Kudlapur's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.